Passage Bio, Inc. (PASG) Misses Q3 EPS by 3c

Passage Bio, Inc. (NASDAQ: PASG) reported Q3 EPS of ($0.49), $0.03 worse than the analyst estimate of ($0.46).

For earnings history and earnings-related data on Passage Bio, Inc. (PASG) click here.

You May Also Be Interested In

• MillerKnoll, Inc. (MLKN) Tops Q1 EPS by 18c ; Offers Guidance
• Activist Corvex seeks Whitbread board seat over strategy concerns
• Amrize Ltd (AMRZ) PT Lowered to $42 at UBS on Lower Earnings Estimates